Testosterone Inhibits Secretion of the Pro-Inflammatory Chemokine CXCL1 from Astrocytes.

CXCL1 LPC androgen astrocyte chemokine demyelination inflammation neuroprotection remyelination testosterone

Journal

Current issues in molecular biology
ISSN: 1467-3045
Titre abrégé: Curr Issues Mol Biol
Pays: Switzerland
ID NLM: 100931761

Informations de publication

Date de publication:
06 Mar 2024
Historique:
received: 21 07 2023
revised: 25 02 2024
accepted: 01 03 2024
medline: 27 3 2024
pubmed: 27 3 2024
entrez: 27 3 2024
Statut: epublish

Résumé

Astrocytes play an important role in the regulation of the inflammatory response in the CNS, e.g., in demyelinating diseases. Since the chemokine CXCL1 is known to be secreted by astrocytes and to have a pro-inflammatory effect on immune cells in the CNS, we verified the effect of testosterone on its secretion in vitro (in the astrocytic cell line DI TNC1). Testosterone reduced the increase in CXCL1 production caused by the pro-inflammatory agent lysophosphatidylcholine and restored the basal production level of CXCL1. The androgen receptor (present and functional in the studied cell line) was strongly suggested to mediate this effect-its non-steroid ligand flutamide exerted an agonist-like effect, mimicking the activity of testosterone itself on CXCL1 secretion. This novel mechanism has important implications for the known immunomodulatory effect of testosterone and potentially other androgenic hormones. It provides a potential explanation on the molecular level and shows that astrocytes are important players in inflammatory homeostasis in the CNS and its hormonal regulation. Therefore, it suggests new directions for the development of the therapeutic intervention.

Identifiants

pubmed: 38534751
pii: cimb46030135
doi: 10.3390/cimb46030135
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2105-2118

Subventions

Organisme : Medical University of Lodz
ID : 502-03/5-062-01/502-54-181
Organisme : Medical University of Lodz
ID : 502-03/5-062-01/502-54-182

Auteurs

Malgorzata Turniak-Kusy (M)

Department of Neurology and Stroke, Medical University of Lodz, 90-549 Lodz, Poland.

Maciej Studzian (M)

Department of Oncobiology and Epigenetics, Faculty of Biology and Environmental Protection, University of Lodz, 90-237 Lodz, Poland.
Laboratory of Transcriptional Regulation, Institute of Medical Biology, Polish Academy of Sciences, 90-364 Lodz, Poland.

Piotr Szpakowski (P)

Department of Neurology and Stroke, Medical University of Lodz, 90-549 Lodz, Poland.

Piotr Kuchta (P)

Faculty of Medicine, Medical University of Lodz, 90-419 Lodz, Poland.

Kaja Smietanka (K)

Department of Neurology and Stroke, Medical University of Lodz, 90-549 Lodz, Poland.

Claudia Mattern (C)

Oceanographic Center, Nova Southeastern University, Fort Lauderdale, FL 33314, USA.
M&P Pharma AG, 6376 Emmetten, Switzerland.

Lukasz Pulaski (L)

Department of Oncobiology and Epigenetics, Faculty of Biology and Environmental Protection, University of Lodz, 90-237 Lodz, Poland.
Laboratory of Transcriptional Regulation, Institute of Medical Biology, Polish Academy of Sciences, 90-364 Lodz, Poland.

Bartosz Bielecki (B)

Department of Neurology, Laboratory of Neuroimmunology, Medical University of Lodz, 90-153 Lodz, Poland.

Classifications MeSH